Skip to main content
Equibles

Katia Schlienger

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Katia Schlienger

HOOKIPA Pharma Inc. reported in an 8-K filed December 15, 2022 that Katia Schlienger was appointed Chief Medical Officer, effective January 1, 2023.

“On December 9, 2022, the Board appointed Katia Schlienger as Chief Medical Officer, effective January 1, 2023.”
HOOKIPA Pharma Inc. Form 8-K, filed December 15, 2022 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

  • HOOKIPA Pharma Inc.

    Proxy statement

    Start not stated–2023-04-13

    Last confirmed by a filing; no departure on record

Company network

Recorded roles and call appearances connecting this person to public companies.

HOOKIPA Pharma Inc.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.